Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 113 | 3 | CARBOHYDRATE RESEARCH//LECTIN//GLYCOSYLATION | 72478 |
| 858 | 2 | CARBOHYDRATE RESEARCH//C GLYCOSIDES//GLYCALS | 11745 |
| 29137 | 1 | TAS 106//DUPLEX DRUG//3 C ETHYNYLCYTIDINE | 210 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | TAS 106 | authKW | 1650883 | 5% | 100% | 11 |
| 2 | DUPLEX DRUG | authKW | 1067236 | 4% | 89% | 8 |
| 3 | 3 C ETHYNYLCYTIDINE | authKW | 675358 | 3% | 75% | 6 |
| 4 | ECYD | authKW | 675358 | 3% | 75% | 6 |
| 5 | 3 ETHYNYLCYTIDINE | authKW | 600321 | 2% | 100% | 4 |
| 6 | CS 682 | authKW | 450241 | 1% | 100% | 3 |
| 7 | 1 3 C ETHYNYL BETA D RIBO PENTOFURANOSYLCYTOSINE | authKW | 300161 | 1% | 100% | 2 |
| 8 | 1 3 C ETHYNYL BETA D RIBOPENTOFURANOSYL URACIL | authKW | 300161 | 1% | 100% | 2 |
| 9 | ANTICANCER RIBO NUCLEOSIDE | authKW | 300161 | 1% | 100% | 2 |
| 10 | DIMERIC PRODRUGS | authKW | 300161 | 1% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Chemistry, Organic | 595 | 25% | 0% | 52 |
| 2 | Oncology | 376 | 23% | 0% | 49 |
| 3 | Chemistry, Medicinal | 233 | 10% | 0% | 22 |
| 4 | Chemistry, Multidisciplinary | 150 | 20% | 0% | 41 |
| 5 | Pharmacology & Pharmacy | 132 | 17% | 0% | 35 |
| 6 | Biochemistry & Molecular Biology | 116 | 23% | 0% | 48 |
| 7 | Chemistry, Applied | 71 | 6% | 0% | 13 |
| 8 | Biophysics | 12 | 4% | 0% | 8 |
| 9 | Crystallography | 4 | 2% | 0% | 4 |
| 10 | Biology | 4 | 2% | 0% | 4 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANC DESIGNATED COMPREHENS CANC | 150080 | 0% | 100% | 1 |
| 2 | CHEM PHARM FOOD SCI | 150080 | 0% | 100% | 1 |
| 3 | LICENSE DEV | 150080 | 0% | 100% | 1 |
| 4 | PHARMACOL EXPT CLINIQUE | 150080 | 0% | 100% | 1 |
| 5 | STATE ONCOL SO CHINASIR YK PAO CANC | 150080 | 0% | 100% | 1 |
| 6 | U716 IGM | 150080 | 0% | 100% | 1 |
| 7 | EXCELLENCE CLIN EXPT ONCOL CLEXO | 75039 | 0% | 50% | 1 |
| 8 | CANC 2 | 64315 | 1% | 14% | 3 |
| 9 | HANNO | 54867 | 3% | 5% | 7 |
| 10 | GEN OPHTHALMOL 1 | 50025 | 0% | 33% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 6275 | 7% | 0% | 14 |
| 2 | INVESTIGATIONAL NEW DRUGS | 2827 | 3% | 0% | 7 |
| 3 | ZHURNAL ORGANICHESKOI KHIMII | 2380 | 5% | 0% | 11 |
| 4 | NUCLEOSIDES & NUCLEOTIDES | 2025 | 1% | 0% | 3 |
| 5 | ZHURNAL OBSHCHEI KHIMII | 1853 | 5% | 0% | 10 |
| 6 | CARBOHYDRATE RESEARCH | 1844 | 6% | 0% | 13 |
| 7 | LIEBIGS ANNALEN DER CHEMIE | 1675 | 3% | 0% | 6 |
| 8 | CHEMISCHE BERICHTE-RECUEIL | 940 | 3% | 0% | 6 |
| 9 | MONATSHEFTE FUR CHEMIE | 587 | 2% | 0% | 5 |
| 10 | JOURNAL OF MEDICINAL CHEMISTRY | 429 | 4% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |